Document is current

Any future updates will be listed below

Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline

Crossref DOI link: https://doi.org/10.1186/s13195-021-00770-2

Published Online: 2021-01-15

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark